Targeted neoadjuvant therapy in the HER-2-positive breast cancer patients: a systematic review and meta-analysis

AIM: To evaluate efficacy and safety of lapatinib or trastuzumab alone or both plus chemotherapy for the treatment of breast cancer patients with positive HER-2 expression. METHODS: Cochrane Central Register of Controlled Trials, PubMed, MEDLINE, OVID, Embase, Chinese Biomedical Literature Database,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Wenhua, Zhao, Fugang, Zhou, Changpeng, Zhang, Yongqian, Zhao, Yingchun, Li, Na, Xie, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322707/
https://www.ncbi.nlm.nih.gov/pubmed/30655674
http://dx.doi.org/10.2147/OTT.S183304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322707/
https://www.ncbi.nlm.nih.gov/pubmed/30655674
http://dx.doi.org/10.2147/OTT.S183304

Ejemplares similares